Business Wire

MAXON Announces Immediate Availability of Cinema 4D Release 19

Jaa

MAXON announces immediate availability of Cinema 4D Release 19 (R19). This next generation of MAXON’s professional 3D application delivers both great tools and enhancements artists can put to use immediately, and provides a peek into the foundations for the future. Designed to serve individual artists as well as large studio environments, Release 19 offers a fast, easy, stable and streamlined workflow to meet today’s challenges in the content creation markets; especially general design, motion graphics, VFX, VR/AR and all types of visualization.

Cinema 4D R19 Feature Highlights Include:

Viewport Improvements – Results so close to final render that client previews can be output using the new native MP4 video support.

MoGraph Enhancements – Added workflow capabilities in Voronoi Fracturing and an all-new Sound Effector.

New Spherical Camera – Lets artists render stereoscopic 360° Virtual Reality videos and dome projections.

New Polygon Reduction Easily reduce entire hierarchies while preserving vertex maps, selection tags and UV coordinates to ensure textures continue to map properly and preserve polygon detail.

Level of Detail (LOD) Object – Define and manage settings to maximize viewport and render speed, or prepare optimized assets for game workflows. Exports FBX for use in popular game engines.

AMD’s Radeon ProRender – Now seamlessly integrated into R19, providing artists with a cross-platform GPU rendering solution.

Revamped Media Core – Completely rewritten software core to increase speed and memory efficiency for image, video and audio formats; native support for MP4 video without QuickTime.

Robust Modeling – A new modeling core with improved support for edges and N-gons can be seen in the Align and Reverse Normals commands.

BodyPaint 3D – Now uses an OpenGL painting engine, giving R19 artists a real-time display of reflections, alpha, bump or normal, and even displacement for improved visual feedback and texture painting when painting color and adding surface details in film, game design and other workflows.

A complete feature list is available at the Release 19 landing page.

European Debut at the IBC 2017 in Amsterdam

MAXON Cinema 4D R19 will make its European debut at the MAXON booth in hall 7, K30 at IBC 2017, which will take place from September 15 – 19, 2017, at the RAI Convention Center in Amsterdam.

In addition, internationally-renowned 3D artists including Peter Eszenyi, Sophia Kyriacou and Tim Clapham as well as other creatives from international studios will share insights into and techniques used on projects created with Cinema 4D. Partners including Google, Insydium, and Redshift will present important workflow integrations with Cinema 4D. Detailed information as well as the live streaming of all presentations will be available at http://www.c4dlive.com/.

Cinema 4D R19 Pricing, Availability and Upgrade Path

Cinema 4D Release 19 is available from MAXON or its authorized dealers. MAXON Service Agreement customers whose MSA is active as of September 1, 2017 will be upgraded automatically. Cinema 4D R19 is available for Mac OS X and Windows; Linux nodes are also available for network rendering. Pricing and distribution information as well as recommended system requirements are available at http://www.maxon.net/.

Imagery and additional information about Cinema 4D R19

Software Screenshots

Pack Shots

Imagery (RGB)

Imagery (CMYK)

New in R19 Website

New in R19 Cineversity Videos

Press Room

About MAXON

Headquartered in Friedrichsdorf, Germany, MAXON Computer is a developer of professional 3D modeling, painting, animation and rendering solutions. Its award-winning Cinema 4D and BodyPaint 3D software products have been used extensively to help create everything from stunning visual effects in top feature films, TV shows and commercials, cutting-edge game cinematics for AAA games, as well for medical illustration, architectural and industrial design applications. MAXON has offices in Germany, USA, United Kingdom, Canada, France, Japan and Singapore. MAXON products are available directly from the web site and its worldwide distribution channel. MAXON is part of the Nemetschek Group.

MAXON Web Resources

Additional information on MAXON can be obtained as follows:

Website

Facebook

Twitter

YouTube

LinkedIn

Google+

Instagram

Contact information

Press Contact
MAXON Computer
US Internal:
press_us@maxon.net
or
US Media Contact:
Vicky Gray-Clark
Ambient Public Relations
408-243-8880
vicky@ambientpr.com
or
UK:
Liam Stacy
press_uk@maxon.net
or
JAPAN:
Toshihide Miyata
press_jp@maxon.net
or
FRANCE:
Eric Godey
press_fr@maxon.net
or
SINGAPORE/ASEAN:
Vincent Ong
press_sg@maxon.net
or
GERMANY and all other countries:
Jessica Wege
press_de@maxon.net

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Ipsen Receives Approval from European Commission for Xermelo® (Telotristat Ethyl) for the Treatment of Carcinoid Syndrome Diarrhea in Patients Inadequately Controlled by Somatostatin Analogue Therapy19.9.2017 19:00Tiedote

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, today announced that the European Commission has approved Xermelo® (telotristat ethyl) 250 mg three times a day (tid) for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analogue (SSA) therapy in adults inadequately controlled by SSA therapy. This approval allows for the marketing of Xermelo® (telotristat ethyl) in the above indication in all 28 member states of the European Union, Norway and Iceland. David Meek, Chief Executive Officer, Ipsen stated: “We are delighted to provide patients suffering from inadequately controlled carcinoid syndrome with a new treatment option in combination with a somatostatin analogue that demonstrates both efficacy and safety in particularly improving diarrhea, a most debilitating symptom. Xe

6th Annual World Patient Safety, Science & Technology Summit to Be Held in London, England19.9.2017 18:00Tiedote

The Patient Safety Movement Foundation (PSMF) announces that the 6th Annual World Patient Safety, Science & Technology Summit will take place in London on February 23-25, 2018. Rt. Hon. Jeremy Hunt MP, the Secretary of State for Health from England’s Department of Health, invited PSMF to hold its 6th annual Summit in London during his speech at the Summit in February of this year. This is the first time the Summit will be held outside of the United States. Over the years, the PSMF has taken an increasingly international scope to reach zero preventable patient deaths by 2020. They currently have over 30 Regional Chapters around the world and partnerships with global organizations such as the World Federation of Societies of Anaesthesiologists (WFSA), European Society of Anaesthesiology (ESA), Global Sepsis Alliance (GSA), the Taiwan Patient Safety Culture Club, Sistema Españo

Vertex Announces Upcoming Presentations of Data at 2017 North American Cystic Fibrosis Conference19.9.2017 17:50Tiedote

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that 11 abstracts from its cystic fibrosis (CF) research and development program will be presented at the annual North American Cystic Fibrosis Conference (NACFC) in Indianapolis, November 2 to 4, 2017. Previously announced data from the Phase 3 EVOLVE and EXPAND studies of the investigational tezacaftor/ivacaftor combination in people with CF ages 12 and older who have certain mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene will be presented for the first time. Additionally, data from the Phase 3 extension study of ORKAMBI® (lumacaftor/ivacaftor) in children with CF ages 6 to 11 who have two copies of the F508del mutation and real-world KALYDECO® (ivacaftor) data will be presented. The company also submitted an abstract for the late-breaking poster session with previously announced Phase 1

Biker Summer 2017 campaign: Last Chance to Win Great Prizes from Moto-tyres.co.uk19.9.2017 16:57Tiedote

Moto-tyres.co.uk wants to know: For the fifth year in a row, the online motorbike shop is asking bikers from ten European countries about their Biker Summer 2017 travel plans, favourite destinations and longest tours. For survey participants, Moto-tyres.co.uk and its sister shops in other European countries are raffling prizes to get every biker’s heart beating faster, including vouchers for new motorbike tyres, a GARMIN motorbike GPS navigation system, and a GoPro camera with helmet attachment. For more information and a link to the survey, go to: www.moto-tyres.co.uk/promotion-biker-summer-2017.html. The Biker Summer 2017 campaign is running until 30th September 2017 – so you still have time to join in and win top-quality equipment for your next bike tour. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170919006105/en/

Andersen Global Expands into Uruguay19.9.2017 16:30Tiedote

Andersen Global announces its expansion into Uruguay through a Collaboration Agreement with Fischer & Schickendantz, one of the country’s leading law firms. The addition of Fischer & Schickendantz continues Andersen Global’s expansion and robust presence within the Latin American region. The team is led by Managing Partner, Juan Federico Fischer. “The addition of Juan Federico and the individuals at Fischer & Schickendantz bring a new depth to our team and our business development efforts in South America, while allowing us to deliver additional services in the region,” said Andersen Tax CEO, Mark Vorsatz. “Uruguay is the next major step in our firm’s growth and is an excellent complement for Andersen Global. The ability to provide a full scope of services in Uruguay offers significant advantages, especially given their large cross border client base and Uruguay’s increase

Horizon Petroleum Enters into Definitive Agreements to Acquire Concessions in Poland19.9.2017 16:05Tiedote

Horizon Petroleum Ltd. (the “Company” or “Horizon”) (TSXV:HPL) is pleased to report that further to its press releases dated June 23, 2017, and July 26, 2017, it has entered into a series of definitive agreements (the “Agreements”) with Dublin-based San Leon Energy plc (“SLE”) regarding the purchase from wholly-owned subsidiaries of SLE and other SLE-controlled entities, of 100% interests in 2 oil & gas concessions in the Republic of Poland known as Cieszyn and Bielsko-Biala (the “Primary Concessions”), plus 100% working interests in 2 additional oil & gas concessions in Poland known as Prusice and Kotlarka, and another concession which is under application (together the “Secondary Concessions”). These concessions cover 3,030km2 and lie within the prolific Rotliegendes Basin and Carpathian Foldbelt, where Horizon intends to target undeveloped conventional natural gas discoveries. Gas infr

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme